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Abstract
Background: Cross-contamination of feed with low concentrations of antimicrobials can occur at production,
transport and/or farm level. Concerns are rising about possible effects of this contaminated feed on resistance
selection in the intestinal microbiota. Therefore, an experiment with pigs was set up, in which intestinal and fecal
concentrations of chlortetracycline (CTC), doxycycline (DOX) and sulfadiazine-trimethoprim (SDZ-TRIM) were
determined after administration of feed containing a 3 % carry-over level of these antimicrobials.
Results: The poor oral bioavailability of tetracyclines resulted in rather high concentrations in cecal and colonic
content and feces at steady-state conditions. A mean concentration of 10 mg/kg CTC and 4 mg/kg DOX in the
feces was reached, which is higher than concentrations that were shown to cause resistance selection. On the
other hand, lower mean levels of SDZ (0.7 mg/kg) and TRIM (< limit of detection of 0.016 mg/kg) were found in
the feces, corresponding with the high oral bioavailability of SDZ and TRIM in pigs.
Conclusions: The relation between the oral bioavailability and intestinal concentrations of the tested antimicrobials,
may be of help in assessing the risks of cross-contaminated feed. However, future research is needed to confirm
our results and to evaluate the effects of these detected concentrations on resistance selection in the intestinal
microbiota of pigs.
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Background
Group administration of veterinary drugs through feed
and drinking water is frequently applied in the pig in-
dustry. Antimicrobials are often administered to pigs by
mixing the feed with an oral powder or premix formula-
tion [1–3]. The important role of group administration
of antimicrobials in the selection of resistant bacteria is
generally recognized [4]. Concerns about antimicrobial
resistance selection have already led to the prohibition
of use of antimicrobials as growth promoters in Europe
since 2006 [5]. However, group medication is still used
extensively in many countries for prophylactic, metaphy-
lactic and therapeutic purposes [3]. Major disadvantages
of group medication are the poor control over dosage
due to differences in feed uptake between sick and
healthy animals, inflexible therapy duration for medi-
cated feed, the risk of carry-over and the inevitable con-
tamination of the environment with antimicrobials [4].
Different types of antimicrobial formulations can be
used to treat animals in group. Premixes (38.2 %), oral
powders (33.7 %) and solutions (19.6 %) each accounted
for a significant share of the total amount of sold antimi-
crobials in 26 European countries in 2013 [1]. However,
the types of antimicrobial formulations used for group
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treatment vary considerably between the individual
countries. In some countries, such as Germany,
Luxembourg, Estonia and Denmark, it seems that oral
powders and solutions are preferred over premix formu-
lations, whereas the opposite applies for countries like
Spain, Portugal, Hungary, Cyprus and the UK [1]. In
Belgium, both oral powders (70 %, for feed and drinking
water) and premixes (20 %) are used frequently [1, 2]. In
this study we focus on medicated feed produced in feed
mills, and thus on premix formulations.
Carry-over of feed additives and veterinary drugs from
a compound feed to a non-target feed is a problem in-
herent to the production of compound feed in feed mills
and the transport, storage and delivery of these feeds [6,
7]. A batch of non-target feed that is produced directly
after a compound feed, is generally called ‘flushing feed’.
So far, only coccidiostats and histomonostats are in-
cluded in the European legislation regarding maximum
allowed levels (3 %) in flushing feeds [8]. In Belgium, a
covenant was established in 2013 between the Belgian
Federal Agency for the Safety of the Food Chain
(FASFC) and the Belgian Compound Feed Industry As-
sociation (BCFIA) [9], in which guidelines for maximum
levels of carry-over were set for antimicrobials (1 % of
the min. approved dose, except 2.5 % for some formula-
tions in rabbit pellet feed), paracetamol (1 %) and
anthelmintics (1–3 % of the max. approved dose, de-
pending on the type of feed). Moreover, due to add-
itional technical requirements for feed mills established
in this covenant, namely adding the drugs or additives at
the end of the production line instead of the middle,
carry-over should be reduced significantly in Belgian
feed mills. Unfortunately, carry-over between different
feed batches occurs not only in feed mills, but also dur-
ing transport and at farm level, which makes it a difficult
issue to control [10]. A study by Putier et al. [11], inves-
tigating carry-over at transport level, indicated that this
route should not be underestimated. In this study, two
types of carry-over (inter-bin and intra-bin) of antimi-
crobials (oxytetracycline and chlortetracycline) were
measured in ten different types of delivery trucks. Inter-
bin carry-over of the two antimicrobials ranged from 0.04
to 1.41 % and intra-bin carry-over ranged from 0 to
0.44 %. Carry-over at farm level remains to be elucidated
but could be of great importance, especially in countries
with a focus on use of oral powders and solutions as these
products are mixed with feed or water at the farm [1].
As a result of cross-contamination of feed, the intes-
tinal microbiota of pigs can be exposed to unintended,
low concentrations of antimicrobials [12]. It is known
that low antimicrobial concentrations can evoke
selection of resistant bacteria in vitro [13, 14] and in vivo
[15]. Moreover, in vitro studies with tetracycline,
trimethoprim, streptomycin, erythromycin and ciprofloxacin
show that the fitness cost for resistance-conferring
mutations or genes selected at sub-MIC (Minimum
Inhibitory Concentration) concentrations is often
lower than for those selected above the MIC [13, 14].
Therefore, these sub-MIC selected mutants would be
more stable in bacterial populations and thus poten-
tially more problematic than mutants selected above
the MIC [16–18].
In order to assess the true effect of cross-contaminated
feed on resistance selection in the intestinal microbiota, it
is necessary to first determine the intestinal concentra-
tions of antimicrobials after administration of such feed.
Indeed, each type of antimicrobial has different pharmaco-
kinetic (PK) properties that determine the fraction of the
orally ingested antimicrobial that remains in the intestines
or is excreted in the bile [19]. The oral bioavailability is a
measure of the rate and extent of a drug reaching the sys-
temic circulation in its unchanged form through intestinal
absorption [20]. As such, this PK property has a significant
impact on the fraction of drug that remains in the
intestinal content. The oral bioavailability is strongly
dependent on the active substance and may be influenced
among others by the formulation type and prandial state
of the animal. In this study, an in vivo experiment
with pigs was set up to determine concentrations in
the intestinal content and the feces of chlortetracyc-
line (CTC), doxycycline (DOX) and sulfadiazine-
trimethoprim (SDZ-TRIM) when administering feed
that contains 3 % of the maximum recommended
dose (MRD). This percentage was chosen considering
the only legally applicable guideline in Belgium re-
garding maximum carry-over levels at the time of the
experiment (2013) [8]. The choice of antimicrobials
was based on two aspects. First, tetracyclines and
sulfonamides are among the most used classes of an-
timicrobials in Belgium when considering oral admin-
istration [21]. Second, the oral bioavailability in pigs
was taken into account. SDZ, typically used in a com-
bined formulation with TRIM because of the synergis-
tic mode of action, has a very high oral bioavailability
in pigs, namely 85–100 % [22, 23]. The same applies
to TRIM (73–92 %) [22, 23]. In contrast, tetracyclines
have a low oral bioavailability in pigs, with CTC even
lower (6 %) than DOX (21–50 %) [24–26].
In the past, studies have been performed to exam-
ine levels of antimicrobials and other drugs in tissues
and eggs when poultry is fed with cross-contaminated
feed [27–29]. Yet no data have been published regarding
intestinal concentrations due to cross-contamination in
pigs or other livestock. The aim of this study was
therefore to determine intestinal concentrations in
pigs of CTC, DOX and SDZ-TRIM, when they were
fed a diet that contains a 3 % carry-over level of
these antimicrobials.
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Methods
Premixes, reagents and standards
The premixes used for the preparation of the experimental
diets were Doxyprex® (active pharmaceutical ingredient,
API: 100 mg DOX hyclate/g premix), provided by Kela
Veterinaria (Sint-Niklaas, Belgium), Aurofac® (API:
250 mg CTC.HCl/g premix) and Tucoprim® (API: 125 mg
SDZ/g premix and 25 mg TRIM/g premix), both provided
by Zoetis (Brussels, Belgium). Analytical standards of
DOX (doxycycline hyclate), CTC (chlortetracycline.HCl),
SDZ and TRIM were obtained from Sigma-Aldrich
(Bornem, Belgium). The internal standards (IS) were
demethylchlortetracycline.HCl (DMCTC, Sigma-Aldrich)
and 13C6-sulfadimethoxine and d9-trimethoprim, both
from Witega (Berlin, Germany). Methanol (CH3OH) and
acetonitrile (CH3CN) were of LC-MS grade and obtained
from Biosolve (Valkenswaard, The Netherlands). Water
was of LC-MS grade and was obtained from Biosolve
(Valkenswaard, The Netherlands) for tetracycline analysis,
and was generated from a Milli Q gradient purification
system (Millipore, Billerica, MA, U.S.) for SDZ and TRIM
analysis. Acetic acid (CH3COOH, >99.99 %) was from
Sigma Aldrich, succinic acid (C4H6O4) from VWR
(Leuven, Belgium) and sodium sulphate (Na2SO4), for-
mic acid (HCOOH), trichloroacetic acid (CCl3COOH)
and sodium hydroxide (NaOH) were from Merck
(Darmstadt, Germany).
Preparation of standard solutions
Standard stock solutions of CTC, DOX and the IS
DMCTC were prepared in CH3OH at a concentration of
1 mg/ml and stored at ≤ −15 °C. Working solutions of
DMCTC at a concentration of 100 μg/ml and 20 μg/ml,
and of CTC and DOX at a concentration of 100 μg/ml
were prepared by appropriate dilution with water. Stand-
ard stock solutions of SDZ and the IS 13C6-sulfadimethox-
ine were prepared in CH3CN/water (50/50, V/V) at a
concentration of 1 mg/ml and stored at ≤ −15 °C.
Standard stock solutions of TRIM and the IS d9-
trimethoprim were prepared in CH3OH and stored
at ≤ −15 °C. For 13C6-sulfadimethoxine and d9-
trimethoprim, working solutions of 1 μg/ml were
prepared in water making use of an intermediate
working solution of 10 μg/ml in CH3CN/water (50/
50, V/V). SDZ and TRIM working solutions of 10 μg/
ml, 1 μg/ml and 0.1 μg/ml were prepared in water
and used for spiking the calibration samples. To pre-
pare sodium succinate 0.1 M, 11.8 g of C4H6O4 was
dissolved in 600 ml of water, 10 M NaOH was added
until pH 4.0 was reached, and water was added to
obtain a final volume of 1000.0 ml. The solution was
stored at 4.0 °C. Solutions of HCOOH (0.1 %),
CCl3COOH (20 %) and CH3COOH (0.1 %) were pre-
pared by appropriate dilutions with water.
Preparation of the experimental feed
Three different batches of experimental diets were pre-
pared. Blank feed (meal n° 9231, AVEVE, Merksem,
Belgium) was mixed with the DOX, CTC and SDZ-
TRIM premixes, respectively. A custom made mixing
device (Silobouw, Zulte, Belgium) was kindly provided
by the Food Science and Technology Unit of Ghent Uni-
versity. The added amounts of antimicrobials were cal-
culated to yield cross-contamination levels in the feed
corresponding to 3 % of the MRD (CTC, 18.6 mg/kg
BW (body weight)/day; DOX, 13.5 mg/kg BW/day; SDZ,
25.0 mg/kg BW/day; TRIM, 5.0 mg/kg BW/day). BW
and daily feed intake were set at 25 and 1.5 kg respect-
ively. Thus, a target concentration of 9.29 mg CTC/kg
feed, 6.76 mg DOX/kg feed, 12.5 mg SDZ/kg feed and
2.50 mg TRIM/kg feed was aimed for. Each premix was
first mixed manually with 10 kg of blank feed, which
was then mixed with the remaining blank feed (120 kg)
in the feed mixer for 25 min. The feed was collected
from the mixer in 13 bags, each containing 10 kg. One
sample of approximately 200 g was taken from bag n° 1,
2, 3, 5, 6, 8, 9, 11, 12 and 13 of each experimental feed
to assess if the target concentration was achieved and to
determine the homogeneity. In this way, samples were
collected at the beginning, middle and at the end of the
mixing stream, in order to monitor the whole mixing
cycle. The samples were kept at room temperature (tR,
15–25 °C) until analysis (within a time frame of 2 weeks).
Animal experiment
Twenty-four pigs with an average BW of 27.0 ± 4.0 kg
were randomly divided into 4 equal groups (3 males and
3 females/group): one control group and three experi-
mental groups. Each group was housed in a strictly sepa-
rated 3 by 4 m pen with a concrete floor and natural
light cycle. The temperature varied between 21 and 25 °C.
The floor was cleaned with water every day just before
sample collection. Ad libitum access to drinking water
and feed was provided throughout the experiment. After a
1-week acclimatization period, each experimental group
received during ten days experimental feed containing 3 %
cross-contamination levels of either CTC, DOX or SDZ-
TRIM. The control group received blank feed (no antimi-
crobials). Individual fecal samples were taken by rectal
stimulation, just before the start of providing the experi-
mental diets and at day 2, 4, 6, 8 and 10 of the experimen-
tal feeding period. In case no individual sample could be
obtained (which was the case for in total 19 time points
from 12 pigs), fresh fecal samples were collected from the
cleaned floor. On day 11, all animals were euthanized
through a combined IM injection of xylazine (4.4 mg/kg
BW), zolazepam and tiletamine (both 2.2 mg/kg BW)
followed by an intracardial injection of 0.3 ml/kg BW of
T61® (MSD, Brussels, Belgium). Immediately after
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euthanasia, samples of cecal content and colonic content
from different sampling segments [proximal colon ascen-
dens (PCA), distal colon ascendens (DCA), colon descen-
dens (CD)] were taken from each animal individually.
The samples were directly stored at −80 °C without
homogenization.
Quantitation of antimicrobials in feed and feces
In-house developed methods were applied for both ana-
lysis of tetracyclines [30, 31] and SDZ-TRIM [27, 28].
a) Tetracyclines analysis
Twenty-five ml of CH3OH were added to 5.0 g of
each feed sample. After 20 min of shaking on an in-
house rotary shaker, samples were centrifuged (6261
g, 10 min, 4 °C). Two-hundred μl of supernatant
were transferred into an Eppendorf tube and 800 μl
of CH3OH were added. After adding 50 μl of IS
(20 μg/ml), samples were vortex mixed. Next, the
samples were filtered (PVDF 0.22 μm Millex-GV,
Millipore, Overijse, Belgium) and transferred to an
autosampler vial and 5 μl was injected onto the LC-
MS/MS instrument.
To 2.0 g of intestinal content or feces, 50 μl of IS
(100 μg/ml) were added. After vortex mixing (15 s),
10.0 ml of sodium succinate solution (0.1 M) were
added and the samples were again vortex mixed
(15 s). Samples were then shaken (20 min, in-house
rotary shaker) and centrifuged (6261 g, 10 min, 4 °C).
The supernatant was transferred to a new plastic tube
and vortex mixed (15 s) after adding 1.0 ml of 20 %
CCl3COOH. These tubes were centrifuged again
(6261 g, 10 min, 4 °C) and the samples were filtered
through a Whatman filter (Whatman n°541, VWR,
Leuven). This filtrate was used for further solid-phase
clean-up. After preconditioning an OASIS® HLB
60 mg/3 ml solid phase extraction column (Waters,
Milford, MA, U.S.) with consecutively 3 ml of
CH3OH, 3 ml of HCl (1 M) and 3 ml of HPLC water,
the filtrate was poured onto the HLB column. The
column was then washed with 1 ml of water and
dried. The analytes were eluted with 3 ml of CH3OH.
The eluate was passed through a PVDF filter, trans-
ferred to an autosampler vial and 5 μl was injected
onto the LC-MS/MS instrument.
The LC system consisted of an Acquity autosampler
and an Acquity binary solvent manager from Waters
(Milford, U.S.). Chromatographic separation was
achieved on an Acquity UPLC BEH C18 column
(50 mm × 2.1 mm i.d., 1.7 μm) from Waters. The
temperatures of the autosampler tray and column
oven were set at 10 °C and 30 °C, respectively.
Mobile phase A consisted of CH3CN whereas
mobile phase B was 0.1 % HCOOH in water. Flow
rate was set at 0.3 ml/min and the following elution
program was run: 0–4.0 min (10 % A), 4.0–5.0 min
(linear gradient to 90 % A), 5.0–7.1 (90 % A), 7.1–7.2
(linear gradient to 10 % A), 7.2–9.0 min (10 % A). The
detection was performed with a Quattro Premier XE
triple quadrupole mass spectrometer, equipped with
an electrospray ionization (ESI) probe operating in the
positive ionization mode (Waters). Masslynx software
v 4.1 was used to quantitate, based on the following
MS-MS transitions: m/z 479.04 > 461.84 (CTC) and
m/z 445.10 > 427.96 (DOX).
b) Sulfadiazine-trimethoprim analysis
After homogenization of the feed sample, 5.0 g of
feed was weighed and 50 μl of each IS (1 mg/ml)
and 25 ml of CH3OH were added. The sample was
vortex mixed, shaken on a horizontal shaker
(Edmund Bühler, Hechingen, Germany) during
30 min, and centrifuged (4000 g, 15 min, tR). Five ml
of the supernatant were evaporated to dryness at 45
± 5 °C under nitrogen. The sample was redissolved
in 10 ml of CH3CN/water (50/50 V/V), vortex
mixed (30 s), diluted to 1/15 in CH3CN/water (50/
50, V/V), vortex mixed (30 s) and transferred to an
autosampler vial.
For intestinal content or feces analysis, 2.0 g of
sample was weighed after homogenization and 40 μl
of each IS (1 μg/ml) were added. The sample was
carefully mixed with 8 g of Na2SO4 with a spatula to
obtain a dry mixture. If necessary, extra Na2SO4 was
added until the sample was dry. After adding 10 ml
of CH3CN, the sample was vortex mixed, shaken
during 30 min (horizontal shaker, Edmund Bühler)
and centrifuged (15 min, 4000 g, tR). Five ml of the
supernatant were then transferred into a glass tube
and evaporated to dryness under nitrogen in a water
bath of 45 °C. Next, the sample was redissolved in
1 ml of an CH3CN/water mixture (50/50, V/V)
containing 0.1 % CH3COOH in water, vortex mixed
(30 s), sonicated (5 min), and filtered through a
PVDF filter into an autosampler vial.
Chromatographic separation was performed on a
Waters Acquity UPLC system. An Acquity UPLC
BEH C18 column (100 mm × 2.1 mm i.d., 1.7 μm)
was used and the analysis was performed with a
gradient of water/CH3CN (95/5, V/V) + 0.3 %
CH3COOH (mobile phase A) and water/CH3CN
(5/95, V/V) + 0.3 % CH3COOH (mobile phase B).
The following elution program was run: 0–8 min
(100 % A), 8–12 min (70 % A), 12–13 min (0 %
A), 13–13.01 min (linear gradient to 100 % A),
13.01–14.6 min (100 % A). Flow rate was set at
0.4 ml/min. A Xevo TQ-MS triple quadrupole
mass spectrometer with an ESI probe operating in
the positive ionization mode was used. Quantitation
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was done with Masslynx software v 4.1. MS-MS tran-
sitions for SDZ were: m/z 250.89 > 155.94/107.96 and
for TRIM: m/z 290.98 > 122.99/230.01. The detected
ion ratio’s for the different samples were within the
permitted tolerances specified in Commission
Decision 2002/657/EC [32].
Method validation
The methods were validated for feed and feces according
to a set of parameters that were in compliance with
the recommendations and guidelines defined by the
European Community [32] and international standards
for validation of analytical methods in residue depletion
studies [33]. The following set of parameters was deter-
mined: limit of detection (LOD, n = 6), limit of quantifica-
tion (LOQ, n = 6), linearity (R2 and goodness-of-fit
coefficient (g)), precision (repeatability, RSDr (n = 6), and
reproducibility, RSDR (n = 6)) and trueness (n = 6).
Validation samples were prepared with blank feed
from the same batch as the feed that was adminis-
tered during the experiment and blank feces were
obtained from pigs that were not treated with anti-
microbial drugs.
Statistical analysis
After determination of normality and homogeneity of
variances, one-way analysis of variance (ANOVA) (SPSS
22, IBM, Chicago, IL, U.S.) was performed for each anti-
microbial on the concentrations from the four different
intestinal segments. A Scheffé test was performed as
post-hoc test. The significance level was set at 0.05.
Results
Method validation
The results of the method validation are given in
Additional file 1: Table S1. All values, except for the
trueness in case of SDZ in feed, were within the ac-
ceptance ranges according to Commission Decision
2002/657/EC [32].
Concentrations in experimental feed
Ten samples of each batch of experimental feed were
analyzed to assess if the target concentrations (3 % of
the MRD) were achieved. Mean concentrations ± stand-
ard deviation (SD) in the feed were 7.33 ± 6.87 mg/kg
(=3.26 % of MRD) for DOX, 9.98 ± 5.35 mg/kg (=3.23 %
of MRD) for CTC, 12.99 ± 4.15 mg/kg (=3.12 % of
MRD) for SDZ and 2.31 ± 0.90 mg/kg (=2.77 % of MRD)
for TRIM. In all experimental diets, there was a high
variation between sample concentrations.
Concentrations in feces
The mean (+ SD) concentrations of CTC, DOX and
SDZ in the feces are shown in Fig. 1. A steady-state was
reached around day 4 for CTC (±10 mg/kg), DOX
(±4 mg/kg) and SDZ (±0.7 mg/kg). Concentrations of
TRIM were very low; all results except two were lower
than the LOD of 0.016 mg/kg. No traces of antimicro-
bials were found in the fecal samples taken on day 0, just
before the start of the experimental period.
Transfer ratio’s (TR), i.e. the mean concentration in
feces taken over day 4 – day 10 of the experimental
period, and divided by the mean concentration in feed,
were 102.5, 55.4 and 4.7 % for CTC, DOX and SDZ,
respectively (Table 1).
Concentrations in cecal and colonic content
CTC, DOX and SDZ concentrations in cecal content
and contents of different segments of the colon after
10 days of feeding are presented in Fig. 2. Min/max/
mean concentrations for CTC in the different intestinal
segments were 4.06/9.15/6.95 mg/kg (caecum, CM),
5.20/13.89/8.41 mg/kg (PCA), 5.14/11.22/7.12 mg/kg
(DCA) and 8.99/11.63/10.08 mg/kg (CD). For DOX,
these concentrations were 1.01/3.07/1.78 mg/kg (CM),
1.47/5.86/3.31 mg/kg (PCA), 1.40/3.51/2.68 mg/kg
(DCA) and 2.80/4.62/3.81 mg/kg (CD). SDZ concentra-
tions were 0.23/0.83/0.47 mg/kg (CM), 0.21/0.67/
0.45 mg/kg (PCA), 0.51/1.00/0.67 mg/kg (DCA) and
0.47/0.65/0.54 mg/kg (CD). All results for TRIM were
again lower than the LOD of 0.016 mg/kg. Concentrations
in the CD approached the average feces concentration
found for CTC, DOX and SDZ. CTC concentrations
found in the CD proved to be significantly higher com-
pared to concentrations in the DCA and the CM, but not
compared to the PCA. DOX levels in the CM were signifi-
cantly lower than in the PCA and CD. SDZ levels in the
DCA were significantly higher than in the PCA. The TR’s,
i.e. the mean concentration in CM, PCA, DCA or CD di-
vided by the mean concentration in the feed, are given in
Table 1.
Discussion
The aim of this study was to determine which concen-
trations of CTC, DOX, SDZ and TRIM could be found
in intestinal content and feces of pigs when feed con-
taining a 3 % carry-over concentration was administered.
In each experimental diet the target concentration of
3 % of the MRD was approached (2.77–3.26 %). Al-
though the best possible sampling procedure [7] was ap-
plied, a large variation between the samples was found.
Adequate mixing of the premixes depends on multiple
factors, including physico-chemical properties such as
particle size and electrostatic properties of the premix.
Other factors that influence homogeneity are the com-
position of the final feed, type of mixing machinery, mix-
ing in stages or trituration and precision and size of the
samples taken for analysis [34]. Since very small volumes
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of premix had to be mixed with large amounts of blank
feed, it is not surprising that a large variability among
samples was found. Moreover, studies on cross-
contamination in feed mills show that antimicrobials are
not homogenously divided in flushing feed either [6]. In
contrast, concentrations found in intestinal content and
feces showed a much lower variation.
In case of SDZ-TRIM, concentrations found in feces
and intestinal content were very low (SDZ max.
0.995 mg/kg, TRIM < LOD). Except for two values, all
results for TRIM were lower than the LOD. Since the
administered dose was very low (2.31 mg/kg feed), the
reported oral bioavailability for TRIM is high (73–92 %
[22, 23]) and elimination occurs through renal excretion,
very low intestinal concentrations were indeed expected.
On the other hand, quantitative results for SDZ were ob-
tained, although the oral bioavailability of SDZ in pigs is
even higher than for TRIM. This can be explained by
the higher absolute dosage of SDZ (12.99 mg/kg feed)
compared to TRIM, as both compounds are present in a
5/1 ratio (SDZ/TRIM) in the used formulation. Inter-
estingly, the calculated TR’s from feed to gut of SDZ
(3.5–5.2 %) correspond well to the high oral bioavailabil-
ity reported in pigs (85–100 % [22, 23]), i.e. the higher the
oral bioavailability the lower residual concentrations in
the gut can be expected unless extensive biliary excretion
or secretion in the gut takes place.
The concentrations of tetracyclines in feces and cecal
and colonic content were found to be relatively high. In
general, higher concentrations were seen in the distal
part of the colon compared to the proximal part and the
caecum. The main explanation for these observations is
probably the progressive absorption of water throughout
the intestinal tract. As in the case of SDZ, the calculated
TR’s from feed to gut (CTC 69.6–102.5 %, DOX 24.3–
55.4 %) correspond well to the reported oral bioavailabil-
ity in pigs (CTC 6 %, DOX 21–50 % [24–26]). It has to
be taken into account though, that the bioavailability of
tetracyclines is highly variable, most likely due to pres-
ence of feed in the gastrointestinal tract. It is known that
oral absorption of tetracyclines may be reduced in the
presence of bivalent ions [24, 35]. Also, the study design
to calculate oral bioavailabilities may vary between dif-
ferent studies, e.g. the prandial state of the animals.
Fig. 1 Mean concentrations (mean of six pigs + standard deviation) of chlortetracycline (CTC), doxycycline (DOX) and sulfadiazine (SDZ) in pig
feces during 10 days of ad libitum feeding with feed containing 3 % cross-contamination levels of these antimicrobials. For CTC, concentrations
rose from 4.97 mg/kg to a steady-state of approximately 10 mg/kg. Mean concentrations of DOX rose from 2.99 mg/kg to a steady-state of
approximately 4 mg/kg. Mean concentrations of SDZ rose from 0.44 mg/kg to a steady-state of approximately 0.70 mg/kg
Table 1 Oral bioavailability (F) compared to transfer ratio’s (TR) of chlortetracycline (CTC), doxycycline (DOX) and sulfadiazine (SDZ)
Antimicrobial F TR
CM PCA DCA CD Feces
CTC 6 % [25] 69.6 % 84.2 % 71.4 % 101.0 % 102.5 %
DOX 21–50 % [24, 26] 24.3 % 45.1 % 36.6 % 51.9 % 55.4 %
SDZ 85–100 % [22, 23] 3.7 % 3.5 % 5.2 % 4.2 % 4.7 %
TR’s are calculated by dividing the mean concentration (6 pigs) in the content of an intestinal segment (CM caecum, PCA proximal colon ascendens, DCA distal
colon ascendens, CD colon descendens) after 10 days of feeding by the mean concentration in the feed. The mean concentration in the feces was taken over day
4 - day 10 (steady-state)
Peeters et al. BMC Veterinary Research  (2016) 12:209 Page 6 of 9
Taking into account that our experiment involves feed
administration, references regarding oral bioavailability
in non-fasted pigs in particular were consulted. Espe-
cially for DOX, the oral bioavailability seems to vary,
even within the same study between individual animals
(8.0–32.4 % [24], 40–50 % [26]). The intestinal concen-
trations of DOX in the present study correspond best to
the oral bioavailability reported in a previous study that
also used a premix formulation (40–50 %) [26] when
compared to administration of an oral powder (8–
32.4 %) [23]. Besides oral bioavailability, also the excre-
tion route can influence the intestinal concentrations of
a drug. SDZ-TRIM and CTC are renally excreted
whereas up to 75 % of DOX is excreted unchanged in
the intestinal tract [36]. It would therefore be expected
that the TR ratio of DOX is higher than based solely on
oral bioavailability. The large variability in reported oral
bioavailabilities for DOX might explain the relatively low
TR indicating that this TR only serves as a guidance
value and depends on several factors.
The oral bioavailability of a drug is usually determined
for its therapeutic dose. Given the inverse relation found
between the oral bioavailability and intestinal concentra-
tions of SDZ, CTC and DOX, it is rather likely that there
is a linear relation between the administered dose and
intestinal concentrations. This information can be used
in the risk assessment of different cross-contamination
levels of pig feed regarding potential resistance selection
in the intestinal microbiota. However, this conclusion
can only be drawn for the tested antimicrobials and
Fig. 2 Concentrations of A) chlortetracycline (CTC), B) doxycycline (DOX) and C) sulfadiazine (SDZ) in cecal content and colonic content from
three different sampling segments (6 indepentent observations per sampling segment). Samples were taken from 6 pigs per group after 10 days
of ad libitum feeding with feed containing 3 % cross-contamination levels of CTC, DOX and SDZ. Mean concentrations in caecum (CM), proximal
colon ascendens (PCA), distal colon ascendens (DCA) and colon descendens (CD) were 6.95, 8.41, 7.12 and 10.08 mg/kg (CTC), 1.78, 3.31, 2.68 and
3.81 mg/kg (DOX) and 0.47, 0.45, 0.67 and 0.54 mg/kg (SDZ), respectively. The two outlying values for CTC (observation 9 and 15) belong to one
animal. A different letter (a or b) denotes a significant difference in concentration between sampling segments (p < 0.05)
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animal species. Furthermore, additional experiments
should be performed to confirm our results - ideally
testing a range of antimicrobial concentrations - as there
is no previous research available to compare. A non-
peer reviewed report [37] though, estimated intestinal
concentrations of CTC to be 1.68 mg/kg in case of ad-
ministration of 12 mg CTC/kg feed. This is clearly lower
compared to our results (min 5.1–max 13.9 mg/kg CTC
in colonic content with 9.98 mg CTC/kg feed).
In a recent study [12], manure samples obtained from
different pig, poultry and veal calve farms in the
Netherlands were examined for the presence of anti-
microbial residues. In 16 out of 20 of the sampled pig
farms, residues were detected although no recent use of
antimicrobials was reported. Tetracyclines were found in
14 of these farms, with DOX concentrations ranging
from 2 to 95,000 μg/kg. Sulfonamides were detected in 6
out of 20 farms, with SDZ concentrations ranging from
1 to 216 μg/kg. In light of these data, it is clear that one
should not focus on the absolute results based on 3 %
carry-over levels obtained in this study, but rather on
the relation found between the oral bioavailability of
CTC, DOX and SDZ and intestinal concentrations.
In recent years, more attention has been paid to the
possible effects of low antimicrobial concentrations on
selection of resistant bacteria. Pioneer studies revealed
important effects of very low concentrations on resistance
selection in vitro. Gullberg et al. performed competition
experiments between strains resistant and susceptible to
tetracycline and found minimal selective concentrations of
15 ng/ml (competition between isogenic - except for the
resistance determinant - SalmonellaTyphimurium strains)
[13] and 45 ng/ml tetracycline (competition between iso-
genic E. coli strains, with or without resistance plasmid
pUUH239.2) [14]. The minimal selective concentration
was in this case defined as the concentration where the
fitness cost of the resistance is balanced by the
antimicrobial-conferred selection for the resistant mutant.
This would mean that even concentrations of tetracyclines
100× lower than those found in this study can cause re-
sistance selection. Brewer et al. [15] investigated the effect
of 1 μg/ml of different antimicrobials on transfer of resist-
ance genes in vivo in pigs and found that 1 μg/ml of tetra-
cycline and sulfamethazine increased transfer frequency,
whereas 1 μg/ml of sulfathiazole did not. It is likely that
intestinal concentrations of 1 μg/ml of tetracyclines can
be found in pigs, considering our results and the max-
imum allowed carry-over level (1 %) established in the
Belgian covenant [9].
Conclusions
This study showed an inverse relation between intestinal
concentrations and the oral bioavailability for SDZ-
TRIM as well as for CTC and DOX, which have a high,
respectively low oral bioavailability in pigs. As different
studies [6, 12] indicate there is a large variation in cross-
contamination levels of feed, this result can be an im-
portant tool to evaluate possible risks of different
contamination levels. Further research is needed to
determine the effect on resistance selection in the intes-
tinal microbiota. Furthermore, it would be interesting to
perform additional experiments, confirming our results
and analyzing other antimicrobials that are frequently
used as premix formulation, such as penicillins, macro-
lides and polymyxins [2].
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